Tiger Medicine: Shareholder Cao Xiaochun releases pledge on 2.32%.

Tiger Pharmaceuticals announced that its shareholder Cao Xiaochun, who holds more than 5% of the shares, repurchased and released 20 million shares on May 13, 2026, accounting for 38.98% of his holdings and 2.32% of the total share capital of the company. The start date is May 13, 2025, with Guotong Securities Asset Management Co., Ltd. as the pledgee. After the transaction, the pledged shares decreased to 18.5 million shares, while the shareholding increased to 51.3142 million shares, with a pledge ratio of 36.05% and accounting for 2.15% of the total share capital of the company.